INSIGHTS ON MANUFACTURING LOGISTICS

• The Interoperability Challenge In Single-Use

  In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists define the main challenge plaguing single-use users: a lack of standards across systems and components. This absence of standardization creates a demand for deep, system-specific expertise that complicates interoperability across the industry and even within an organization. They discuss the many layers of nuance and complexity that make large-scale standardization difficult.

• Addressing Mismatched Connectors And Overcoming Validation Hurdles

  During the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” audience members indicated mismatched connectors and validation challenges as their biggest pain points. In this segment, our panelists respond to the audience and weigh in on how to mitigate these difficulties.

• Planning For Flexibility And Supply Chain Resilience

  In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists discuss the importance of working with your quality team to plan for flexibility, a lesson the industry learned the hard way during the COVID-19 supply chain disruptions.

• Single-Use Standardization Starts Internally

  We've all heard the expression: If you want to change the world, start at home. Single-use standardization is no different. In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists Mark Petrich, Ph.D., and Frank Gillam, Ph.D., reflect on their success and struggles standardizing single-use systems within their respective organizations.

• Leveraging Single-Use Solutions To Solve Working Cell Bank Challenges

  8/28/2025

  Discover how custom manifolds enhance allogeneic therapy development from formulation to commercialization by improving process control, scalability, and efficiency.

• Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

  8/12/2025

  On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.

• Secure Your Sensitive Drug Substances

  8/7/2025

  Explore the risks of freeze and thaw cycles on biological products and how an advanced plate freezing platform protects sensitive molecules with precision and ease.

• Producing MSC-Derived Cell Therapies From Isolation To Large-Scale Expansion

  8/4/2025

  Explore the journey of producing MSC-derived cell therapies, from initial isolation and expansion to final product formulation and storage, and learn how to optimize each step.

• Six Important Considerations For Choosing The Right Laboratory Refrigerators And Freezers

  7/22/2025

  Laboratory refrigerators and freezers are essential for preserving research integrity. Learn six key factors to consider when choosing cold storage solutions to protect your samples.